Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 1c
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $1.00, $0.01 better than the analyst estimate of $0.99. Revenue for the quarter came in at $2.14 billion versus the consensus estimate of $2.07 billion.